RxDoctor Payments Data

Ari Holtzman, MD

Orthopaedic Surgery of the Spine · Tacoma, WANPI 1427580760

Payments from drug & device makers

What this record shows

8 manufacturers reported payments, led by Alphatec Spine, Inc at 48.5% of the total. Reporting peaked in 2023 at $2,092 and has fallen 89.1% since, to $228 in 2025. That places this record below the midpoint for orthopaedic surgery of the spine clinicians in WA, where the typical reported total is $7,316.

$3,505in general payments, 2019–2025

Across 29 payments — averaging $120.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alphatec Spine, Inc$2K
  • Medtronic$997
  • Johnson & Johnson$584
  • Globus Medical$71
  • Baxter Healthcare$50
  • DJO, LLC$44
  • plus $61 from 2 others

What the payments were for

  • Travel & lodging$1,65547%
  • Food & beverage$1,85053%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,505 in reported general payments places this provider in the 35th percentile of 61 orthopaedic surgery of the spine providers in Washington.

See all orthopaedic surgery of the spine providers in Washington

Medicare billing

Part B allowed, 2024
$196,166
Medicare patients
306
Services billed
1,194

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Calcitonin-SalmonCalcitonin,salmon,synthetic12$736
Oxycodone Hcl70$378
Methocarbamol41$313
Gabapentin22$218
Cyclobenzaprine Hcl22$186
Naproxen29$146
Meloxicam47$131
Methylprednisolone14$108
Hydroxyzine Pamoate13$64

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Tacoma

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →